comparemela.com

Latest Breaking News On - மார்செலோ பிகுேரச் - Page 1 : comparemela.com

Comenzarán a repartir segundas dosis de Sputnik producidas en la Argentina

Comenzarán a repartir segundas dosis de Sputnik producidas en la Argentina
analisisdigital.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from analisisdigital.com.ar Daily Mail and Mail on Sunday newspapers.

Vacuna Sputnik V: se distribuyen las primeras dosis 2 terminadas en Argentina

Vacuna Sputnik V: se distribuyen las primeras dosis 2 terminadas en Argentina
primerafuente.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from primerafuente.com.ar Daily Mail and Mail on Sunday newspapers.

Bomba: los jueces que visitaron a Alberto Fernández en pleno aislamiento

Bomba: los jueces que visitaron a Alberto Fernández en pleno aislamiento
mdzol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mdzol.com Daily Mail and Mail on Sunday newspapers.

Buenos Aires Times | Argentina to produce three million Sputnik V second doses in August

Share this News Laboratorios Richmond confirmed late Friday that it has completed the first locally made batch of doses of Sputnik V vaccine. | Laboratorios Richomond Twitter The Russian Direct Investment Fund (RDIF) has confirmed that it has reached an agreement that will see three million doses of the second component of the Sputnik V produced in Argentina over the next month. Laboratorios Richmond SA, based in Buenos Aires Province, will begin producing the second shot of the Russian-made jab this week, said the sovereign wealth fund, which is in charge of the international deployment of the anti-Covid vaccine. “The Russian Direct Investment Fund and Argentina’s Laboratorios Richmond SACIF pharmaceutical company today announced the Sputnik V vaccine produced at company’s facilities will become available for vaccination in Argentina starting from this week following successful quality control of test samples at the Gamaleya Center on August 3,” read a statement, which

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.